BACKGROUND: Recent pathological studies report vascular pathology in clinically diagnosed Alzheimer's disease (AD) and AD pathology in clinically diagnosed vascular dementia (VaD). We compared magnetic resonance imaging (MRI) measures of vascular brain injury (white matter hyperintensities [WMH] and infarcts) with neurodegenerative measures (medial-temporal atrophy [MTA] and cerebral atrophy [CA]) in clinically diagnosed subjects with either AD or VaD. We then examined relationships among these measures within and between the two groups and their relationship to mental status. METHODS: Semi-quantitative MRI measures were derived from blind ratings of MRI scans obtained from participants in a research clinical trial of VaD (N = 694) and a genetic epidemiological study of AD (N = 655). RESULTS:CA was similar in the two groups, but differences in the mean of MTA and WMH were pronounced. Infarcts were significantly associated with CA in VaD but not in AD; MTA and WMH were associated with CA in both. WMH was associated with MTA in both groups; however, MRI infarcts were associated with MTA in VaD but not with MTA in AD patients. MTA was strongly associated with Mini-Mental State Examination scores in both groups, whereas evidence of a modest association between WMH and Mini-Mental State Examination scores was seen in VaD patients. CONCLUSIONS: MRI data from two dementia cohorts with differing dementia etiologies find that the clinical consequences of dementia are most strongly associated with cerebral and medial-temporal atrophy, suggesting that tissue loss is the major substrate of the dementia syndrome.
RCT Entities:
BACKGROUND: Recent pathological studies report vascular pathology in clinically diagnosed Alzheimer's disease (AD) and AD pathology in clinically diagnosed vascular dementia (VaD). We compared magnetic resonance imaging (MRI) measures of vascular brain injury (white matter hyperintensities [WMH] and infarcts) with neurodegenerative measures (medial-temporal atrophy [MTA] and cerebral atrophy [CA]) in clinically diagnosed subjects with either AD or VaD. We then examined relationships among these measures within and between the two groups and their relationship to mental status. METHODS: Semi-quantitative MRI measures were derived from blind ratings of MRI scans obtained from participants in a research clinical trial of VaD (N = 694) and a genetic epidemiological study of AD (N = 655). RESULTS: CA was similar in the two groups, but differences in the mean of MTA and WMH were pronounced. Infarcts were significantly associated with CA in VaD but not in AD; MTA and WMH were associated with CA in both. WMH was associated with MTA in both groups; however, MRI infarcts were associated with MTA in VaD but not with MTA in ADpatients. MTA was strongly associated with Mini-Mental State Examination scores in both groups, whereas evidence of a modest association between WMH and Mini-Mental State Examination scores was seen in VaD patients. CONCLUSIONS: MRI data from two dementia cohorts with differing dementia etiologies find that the clinical consequences of dementia are most strongly associated with cerebral and medial-temporal atrophy, suggesting that tissue loss is the major substrate of the dementia syndrome.
Authors: Robert C Green; L Adrienne Cupples; Rodney Go; Kelly S Benke; Timi Edeki; Patrick A Griffith; Mary Williams; Yvonne Hipps; Neill Graff-Radford; David Bachman; Lindsay A Farrer Journal: JAMA Date: 2002-01-16 Impact factor: 56.272
Authors: S Demissie; R C Green; L Mucci; S Tziavas; K Martelli; K Bang; L Coons; S Bourque; D Buchillon; K Johnson; T Smith; N Sharrow; N Lautenschlager; R Friedland; L A Cupples; L A Farrer Journal: Neuroepidemiology Date: 2001-05 Impact factor: 3.282
Authors: J A Schneider; R S Wilson; E J Cochran; J L Bienias; S E Arnold; D A Evans; D A Bennett Journal: Neurology Date: 2003-04-08 Impact factor: 9.910
Authors: C R Jack; D W Dickson; J E Parisi; Y C Xu; R H Cha; P C O'Brien; S D Edland; G E Smith; B F Boeve; E G Tangalos; E Kokmen; R C Petersen Journal: Neurology Date: 2002-03-12 Impact factor: 9.910
Authors: David S Knopman; Joseph E Parisi; Bradley F Boeve; Ruth H Cha; Hulya Apaydin; Alessandro Salviati; Steven D Edland; Walter A Rocca Journal: Arch Neurol Date: 2003-04
Authors: G Fein; V Di Sclafani; J Tanabe; V Cardenas; M W Weiner; W J Jagust; B R Reed; D Norman; N Schuff; L Kusdra; T Greenfield; H Chui Journal: Neurology Date: 2000-12-12 Impact factor: 9.910
Authors: D Leys; T Erkinjuntti; D W Desmond; R Schmidt; E Englund; F Pasquier; L Parnetti; J Ghika; R N Kalaria; H Chabriat; P Scheltens; J Bogousslavsky Journal: Alzheimer Dis Assoc Disord Date: 1999 Oct-Dec Impact factor: 2.703
Authors: Ysbrand D Van der Werf; Philip Scheltens; Jaap Lindeboom; Menno P Witter; Harry B M Uylings; Jelle Jolles Journal: Neuropsychologia Date: 2003 Impact factor: 3.139
Authors: A T Du; N Schuff; M P Laakso; X P Zhu; W J Jagust; K Yaffe; J H Kramer; B L Miller; B R Reed; D Norman; H C Chui; M W Weiner Journal: Neurology Date: 2002-06-11 Impact factor: 9.910
Authors: Chenyang Li; Henry Rusinek; Jingyun Chen; Louisa Bokacheva; Alok Vedvyas; Arjun V Masurkar; E Mark Haacke; Thomas Wisniewski; Yulin Ge Journal: Front Aging Neurosci Date: 2022-09-01 Impact factor: 5.702